Leena Tiainen

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Yanina Jansen, Elisa A. Rozeman, Robert M. Mason et al. · Annals of Oncology · 2019 · 228 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer

Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala et al. · Clinical Breast Cancer · 2019 · 52 citations · Full text

Medicine, Immunology, Oncology +15

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma

Joonas Terävä, Leena Tiainen, Urpo Lamminmäki et al. · PLoS ONE · 2019 · 52 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer

Leena Tiainen, Minna Tanner, Outi Lahdenperä et al. · Anticancer Research · 2016 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

High baseline Tie1 level predicts poor survival in metastatic breast cancer

Leena Tiainen, Emilia A. Korhonen, Veli‐Matti Leppänen et al. · BMC Cancer · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17